Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov ID: NCT02847598

Public ClinicalTrials.gov record NCT02847598. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of the study is to evaluate the efficacy of BIIB059 (litifilimab) in reducing disease activity in participants with systemic lupus erythematosus (SLE) with active cutaneous manifestations and joint involvement (Part A), and in participants with active cutaneous lupus erythematosus (CLE) (Subacute cutaneous lupus erythematosus (SCLE) or chronic CLE, including discoid lupus erythematosus (DLE)) with or without systemic manifestations (Part B). The secondary objective is to evaluate additional efficacy parameters of BIIB059 in reducing SLE/CLE disease activity, pharmacokinetic parameters, safety and tolerability of BIIB059 (Parts A and B).

Study identification

NCT ID
NCT02847598
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biogen
Industry
Enrollment
264 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 20, 2016 (Actual)
Primary completion
Aug 28, 2019 (Actual)
Completion
Nov 18, 2019 (Actual)
Last update posted
Nov 7, 2023

2016 – 2019

United States locations

U.S. sites
53
U.S. states
24
U.S. cities
47
Facility City State ZIP Site status
Pinnacle Research Group LLC Anniston Alabama 36207 —
Arizona Arthritis & Rheumatology Phoenix Arizona 85037 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
TriWest Research Associates, LLC El Cajon California 92020 —
Tien Q Nguyen MD Inc Fountain Valley California 92708 —
MD Med Corp Hemet California 92543 —
Universtiy of California, Irvine Irvine California 92697 —
The Regents of the University of California La Jolla California 92037 —
Purushotham Akther & Rosan Kotha, MD Inc. La Mesa California 92120 —
Dermatology Reserach Associates Los Angeles California 90045 —
University Clinical Trials San Diego California 92123 —
Richard Barthel, MD Santa Barbara California 93108 —
Robin K. Dore, MD, Inc. Tustin California 92780 —
Inland Rheumatology Clinical Trials Inc. Upland California 91786 —
Nazanin Firooz, MD Inc. West Hills California 91307 —
Denver Arthritis Clinic Denver Colorado 80230 —
Medical Faculty Associates, Inc. Washington D.C. District of Columbia 20037 —
Howard University Hospital Washington D.C. District of Columbia 20060 —
Washington DC VA Medical Center Washington D.C. District of Columbia 20422 —
Clinical Research of West Florida- Corporate Clearwater Florida 33765 —
Medical Research Center Of Miami Miami Florida 33144 —
Lakes Research, LLC Miami Lakes Florida 33014 —
Omega Research Consultants Orlando Florida 32804 —
Compass Research, LLC Orlando Florida 32806 —
DMI Research, Inc. Pinellas Park Florida 33710 —
Advanced Medical Reserarch, PC Sandy Springs Georgia 30328 —
Advanced Clinical Research Boise Idaho 83642 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Washington University School of Medicine St Louis Missouri 63110 —
Davis Group, LTD Las Vegas Nevada 89128 —
Valley Hospital Ridgewood New Jersey 07450 —
Institute for Rheumatic & Autoimmune diseases, Overlook Medical Center Summit New Jersey 07901 —
Albuquerque Center For Rheumatology Albuquerque New Mexico 87102 —
North Shore/Long Island Jewish PRIME Great Neck New York 11020 —
Univeristy of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Joint and Muscle Research Institute Charlotte North Carolina 28204 —
American Health Research, Inc. Charlotte North Carolina 28207 —
Medication Management, LLC Greensboro North Carolina 27408 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Ohio State University Clinical Trials Columbus Ohio 43215 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburg Medical Center Pittsburgh Pennsylvania 15213 —
UPMC Arthritis Center Pittsburgh Pennsylvania 15213 —
Medical University of South Carolina Charleston South Carolina 29425 —
Low Country Rheumatology, PA North Charleston South Carolina 29406 —
University of Tennessee Health Sciences Center Memphis Tennessee 38104 —
Austin Regional Clinic, P.A. Austin Texas 78731 —
UT Southwestern Medical Center Dallas Texas 75390 —
Accurate Clinical Research, Inc. Houston Texas 77034 —
Pioneer Research Solutions, Inc. Houston Texas 77099 —
Virginia Clinical Research Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02847598, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2023 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02847598 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →